Jan C. Buckner

Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.

T. Cascino, J. Buckner, M. Malkin, 1999, Mayo Clinic proceedings.

Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.

E. Galanis, K. Jaeckle, E. Pajon, 2012 .

Phase Ii Trial of Vorinostat in Combination with Bortezomib in Recurrent Glioblastoma: a North Central Cancer Treatment Group Study Neuro-onco Lo Gy

E. Galanis, K. Jaeckle, E. Pajon, 2022 .

Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors.

J. O'fallon, E. Shaw, J. Buckner, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases.

J. Buckner, A. Asher, C. Ménard, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.